Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar mdriver78 (< 20) Submitted: 4/15/08 9:05 AM : Outperform Start Price: $11.23 ALKS Score: 24.71

Forecast 38-percent earings growth over the next 5 years.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links